Brad Gould Appointed Director – Device & Combination Product Development at AbbVie — Pioneering Innovation, Driving Excellence, and Advancing Patient-Centric Solutions
AbbVie is proud to announce the appointment of Brad Gould as Director – Device & Combination Product Development, a role in which his leadership will be central to accelerating innovation in drug delivery systems and combination product design. With over two decades of experience spanning medical devices, pharmaceutical development, and cross-functional product leadership, Brad brings a rare blend of technical mastery, regulatory expertise, and visionary thinking to one of the most critical and fast-evolving areas of healthcare.
A Strategic Innovator at the Forefront of Combination Products
Brad’s journey to AbbVie reflects a career dedicated to bridging engineering precision with patient needs. Throughout his professional tenure, he has consistently delivered products that combine safety, efficacy, and usability — ensuring patients not only receive advanced therapies but can do so with ease, comfort, and confidence. His leadership has driven cross-disciplinary teams to develop devices and systems that meet stringent global regulations while maintaining the highest standards of innovation and quality.
Now, as Director, Brad will:
- Lead the design, development, and lifecycle management of combination products that integrate cutting-edge drug delivery mechanisms.
- Champion human factors engineering to ensure every product is intuitive, accessible, and aligned with real-world patient experiences.
- Drive regulatory alignment and quality compliance across global markets.
- Foster collaboration between R&D, manufacturing, and commercial teams to bring life-changing therapies to patients faster.
Career Milestones & Industry Impact
Before joining AbbVie, Brad made significant contributions to leading healthcare and medical device companies, where he:
- Spearheaded the development of next-generation drug delivery platforms, from concept through market launch.
- Led cross-functional engineering teams in the integration of biologics with advanced device technologies.
- Partnered with regulatory authorities to achieve global approvals for complex combination products.
- Implemented process optimizations that reduced development timelines without compromising safety or quality.
A Leadership Philosophy Built on Excellence and Empathy
What sets Brad apart is his deep belief that innovation in healthcare is not only about technical breakthroughs but also about human impact. He understands that every device and combination product has a direct effect on a patient’s daily life — and he instills this patient-first perspective in every project he leads. His leadership style blends rigorous engineering discipline with compassionate design thinking, ensuring AbbVie remains a leader in delivering therapies that truly improve quality of life.
Shaping the Future of Healthcare at AbbVie
Brad’s appointment marks a significant step in AbbVie’s mission to transform the treatment landscape through device-enabled therapies. His expertise will be pivotal in bringing to market innovative, compliant, and user-focused solutions that align with the company’s vision of improving patient outcomes worldwide.
This announcement is proudly featured by CXO Gateway, a premier platform spotlighting the leadership journeys, strategic impact, and visionary thinking of top executives worldwide. Under the leadership of Brad Gould, CXO Gateway continues to connect the global business community with stories that inspire innovation, foster collaboration, and shape the future of corporate excellence.